Demcon Delft supports Project March

Demcon Delft supports Project MARCH, a group of students working on the development and improvement of an exoskeleton for people with paraplegia. We support the team with financial support, engineering support and workshops.

Demcon is member of the Netherlands Academy of Engineering (NAE)

We are proud to be part of the Netherlands Academy of Engineering (NAE) — a dynamic network that brings together top experts in technological sciences, applied research, and innovation from both academia and industry. Our CEO, Dennis Schipper, is a Fellow within this esteemed community.

Demcon contributes to new design for local hydrogen production

Led by researchers from Saxion University of Applied Sciences, companies (including Demcon), partners and students have jointly designed an innovative electrolysis system. This system for decentralized hydrogen production uses wind and solar energy to produce hydrogen locally. The hydrogen is subsequently stored and converted to energy when needed. This innovative design, stemming from the HYGENESYS research project, helps combat grid congestion and provides a more stable sustainable energy supply.

Demcon suster acquires Coraltech

Demcon continues to expand the activities in the field of the circular economy and sustainable process technology. Over two years ago, Suster, a spin-off from the University of Twente in the field of chemistry and process technology, became part of the Demcon group. As part of Demcon, was Suster able to grow further with research and process development for greening the process industry.

DemcAir ventilation systems get renewed purpose in Ukraine

In 2020, during the hectic early days of the pandemic, intensive care units faced a serious shortage of ventilation equipment for corona patients. At the request of the Ministry of Health, Welfare and Sport (VWS), Demcon rapidly developed the DemcAir ventilation system.

DEMCON Unmanned Systems moved to De Zuid in Scheveningen

From 1 June, DEMCON unmanned systems is the proud tenant of the commercial property below the apartments realized as part of the second-phase development of ZUIDHAVEN in DE ZUID in The Hague. This strategic relocation marks a new chapter for Demcon and underscores the company’s ambition of further consolidating its position in the maritime and unmanned technology sector.

TNO and Demcon explore new joint venture in optics

TNO and Demcon have announced plans for a new joint venture aimed at bringing advanced technology for deformable mirrors to the global market.

SEISMIC consortium secures €23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments

Curix, part of the Demcon group, today announced that the SEISMIC research consortium, coordinated by Philips, together with the Erasmus MC as academic lead, has been awarded funding from the Innovative Health Initiative (IHI) to transform neurosurgery through the seamless integration of minimally invasive surgical techniques and advanced imaging technologies. The EUR 23.5 million public funding will be complemented by EUR 14.9 million in in-kind contributions and additional resources from industry partners, supporting a five-year research and innovation program that also includes eight clinical studies.

Demcon bolstered with the electronics expertise of Leap Development

Technology developer and producer Demcon further expands its technological capabilities with the introduction of Leap Development into the Demcon group. The company will continue its activities under the banner of Demcon electronics. The Deventer-based organization specializes in RF technology, wireless communication, embedded systems and integrated electronics development. With this latest addition, the Demcon group now has a specialized company that is dedicated entirely to electronics development projects and has state-of-the-art testing facilities.

Groundbreaking technology for the treatment of neurological diseases

Curix, part of the Demcon group, is developing groundbreaking technology for the treatment of life-threatening and debilitating neurological diseases. This new technology makes it possible to temporarily open the blood-brain barrier, addressing one of the biggest challenges in neurology. With this technology, drugs for brain tumors and neurodegenerative conditions, such as Alzheimer's and Parkinson's disease, can be delivered more efficiently. The participation of Twinning Participaties allows Curix to develop an injector system suitable for initial clinical studies in humans. “Our ultimate goal is to contribute to the development of improved treatments for neurological diseases”, says Peter Frinking, managing director and chief scientific officer at Curix.

View all items

events

meet us.

We are happy to share our knowledge of technology and our experiences with innovations during events throughout the year. We are also always looking for new ideas, partners and talents. We would love to meet you!

October 26, 2026

news.

Demcon Delft supports Project March

Demcon is member of the Netherlands Academy of Engineering (NAE)

Demcon contributes to new design for local hydrogen production

Demcon suster acquires Coraltech

DemcAir ventilation systems get renewed purpose in Ukraine

DEMCON Unmanned Systems moved to De Zuid in Scheveningen

press releases.

TNO and Demcon explore new joint venture in optics

SEISMIC consortium secures €23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments

Demcon bolstered with the electronics expertise of Leap Development

Groundbreaking technology for the treatment of neurological diseases

we are happy to get in touch with you.

Marleen Markvoort

meet us.

Big Science Business Forum 2026

American Autonomic Society 2026 Conference

Medica

Contact us